ArticleCell biochemistry and biophysics2026
In vivo and In Silico Assessment of Acampe papillosa (Lindl.) Lindl. Seed Extract: A Multi-Pharmacological Approach.
Article in Cell biochemistry and biophysics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acampe papillosa (Lindl.) Lindl., an epiphytic orchid, has been traditionally utilized in ethnomedicine for the management of pyrexia, otalgia, rheumatism, and neuralgia. This work intends to figure out the in vivo neuropharmacological, antinociceptive, and antipyretic potentials of the methanolic extract of A. papillosa seeds (ME-APS) along with computational approaches. Phytochemical screening of ME-APS was analyzed through GC-MS. Elevated plus maze (EPM) and hole board (HBT), forced swim (FST), and tail suspension (TST) tests were used to evaluate anxiolytic and antidepressant effects, whereas acetic acid-induced writhing and formalin-induced paw licking were employed to assess antinociceptive action. Antipyretic activity was examined on the brewer's yeast-induced pyrexia model. Molecular docking and ADME/T analyses were conducted to support the experimental findings. GC-MS analysis revealed 13 prominent bioactive compounds within ME-APS. The extract demonstrated significant, dose-dependent antipyretic and central analgesic activities (p < 0.001) at dosages of 200 and 400 mg/kg. Furthermore, at 200 mg/kg, the extract manifested robust peripheral analgesic and antidepressant-like effects (p < 0.01), alongside a moderate anxiolytic response in the HBT model. Molecular docking studies supported the experimental findings by identifying favorable interactions between selected phytoconstituents and protein targets associated with pain, pyrexia, and neuropharmacological pathways. Based on the computational analysis, the identified compounds exhibited binding affinities ranging from - 4.4 to - 10.1 kcal/mol across the targeted proteins. Furthermore, in silico ADME/T analysis predicted favorable pharmacokinetic characteristics and low toxicity risks for the identified phytoconstituents. Overall, the findings suggest that A. papillosa seeds contain bioactive constituents that may contribute to neuropharmacological, antinociceptive, and antipyretic activities. Further studies, including detailed biochemical and receptor-based investigations, as well as long-term experimental models, are required to confirm these effects.
Indexed as
Identifiers
42631823What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.